IN2015DN01737A - - Google Patents

Download PDF

Info

Publication number
IN2015DN01737A
IN2015DN01737A IN1737DEN2015A IN2015DN01737A IN 2015DN01737 A IN2015DN01737 A IN 2015DN01737A IN 1737DEN2015 A IN1737DEN2015 A IN 1737DEN2015A IN 2015DN01737 A IN2015DN01737 A IN 2015DN01737A
Authority
IN
India
Prior art keywords
stem cells
mesenchymal stem
culturing
concentration
viability
Prior art date
Application number
Other languages
English (en)
Inventor
Yoon Sun Yang
Won Il Oh
Sun Jae Kwon
Mi Yeon Lee
Hong Bae Jeon
Original Assignee
Medipost Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipost Co Ltd filed Critical Medipost Co Ltd
Publication of IN2015DN01737A publication Critical patent/IN2015DN01737A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0665Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/02Atmosphere, e.g. low oxygen conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14Calcium; Ca chelators; Calcitonin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/16Magnesium; Mg chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN1737DEN2015 2012-09-03 2013-09-02 IN2015DN01737A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120097193A KR101532556B1 (ko) 2012-09-03 2012-09-03 간엽줄기세포의 배양 방법
PCT/KR2013/007891 WO2014035215A1 (en) 2012-09-03 2013-09-02 Method for culturing mesenchymal stem cells

Publications (1)

Publication Number Publication Date
IN2015DN01737A true IN2015DN01737A (zh) 2015-05-29

Family

ID=50183937

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1737DEN2015 IN2015DN01737A (zh) 2012-09-03 2013-09-02

Country Status (13)

Country Link
US (3) US9580687B2 (zh)
EP (1) EP2893001B1 (zh)
JP (1) JP6478243B2 (zh)
KR (1) KR101532556B1 (zh)
CN (1) CN104781394B (zh)
AU (1) AU2013309642B2 (zh)
CA (1) CA2884000C (zh)
DK (1) DK2893001T3 (zh)
ES (1) ES2755802T3 (zh)
IN (1) IN2015DN01737A (zh)
PL (1) PL2893001T3 (zh)
PT (1) PT2893001T (zh)
WO (1) WO2014035215A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015170347A2 (en) * 2014-05-09 2015-11-12 Reelabs Private Limited Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
JP6519727B2 (ja) * 2014-09-17 2019-05-29 国立大学法人山口大学 間葉系幹細胞の培養方法、および肝機能障害用治療剤の製造方法
US11000694B2 (en) 2014-10-24 2021-05-11 The Board Of Trustees Of The University Of Illinois Use of lasers for treating and reversing fibrosis
CA2968048A1 (en) * 2014-10-29 2016-05-06 R Bio Co., Ltd. Medium composition for culturing stem cells
JP6898706B2 (ja) * 2015-01-05 2021-07-07 ナショナル ヤン−ミン ユニバーシティ 肝疾患を治療するための間葉系幹細胞
WO2016131430A1 (en) * 2015-02-20 2016-08-25 Shih-Chieh Hung Use of mesenchymal stem cells in treating osteoarthritis
EP3299023A4 (en) * 2015-05-21 2019-03-20 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences MESENCHYMAL SUBSTITUTE CELL CULTIVATED IN HYPOXIA AND USE THEREOF
KR102409483B1 (ko) * 2016-03-31 2022-06-16 샌바이오, 인크. 줄기 세포 배양 및 치료를 위한 배지, 방법, 세포 및 분비 인자
TW201920654A (zh) * 2017-06-05 2019-06-01 加州大學董事會 用來治療視網膜疾病的組合物及其製造與使用方法
CN107384858A (zh) * 2017-08-17 2017-11-24 成都康景生物科技有限公司 一种缺氧耐受型间充质干细胞的制备方法及其应用
CN109666631A (zh) * 2017-10-17 2019-04-23 澳门大学 增强干细胞活性的培养方法、应用以及用于治疗中枢神经疾病的制剂、制备方法及治疗方法
CN109706115B (zh) * 2017-10-26 2023-05-30 中国医科大学 一种小鼠骨髓间充质干细胞细胞系的构建方法
CN108359637B (zh) * 2018-02-14 2021-09-28 浙江生创精准医疗科技有限公司 一种宫血干细胞快速扩增的方法
CN109517786B (zh) * 2018-10-18 2022-06-17 广州元帅生物科技有限公司 一种具有修复功能的多能干细胞制剂及其应用
WO2021040735A1 (en) * 2019-08-30 2021-03-04 The Texas A&M University System Xenogen-free mesenchymal stem cell compositions and methods of use
WO2022004938A1 (ko) * 2020-06-30 2022-01-06 주식회사 미래셀바이오 유사 중간엽 줄기세포의 제조방법
CN112147340B (zh) * 2020-09-30 2024-03-08 北京银丰鼎诚生物工程技术有限公司 一种神经干细胞免疫调节功能的检测方法
CN112375733B (zh) * 2020-11-03 2022-09-02 中国人民解放军陆军军医大学第一附属医院 可增进间充质干细胞干细胞性的植物血凝素及其在间充质干细胞扩增培养中的应用
CN113502261B (zh) * 2021-07-16 2023-08-29 上海东方星际干细胞科技有限公司 一种能高效分化成脂的规模化3d低氧间充质干细胞培养体系
CN116218770B (zh) * 2022-12-30 2023-11-24 苏州科为康生物医药科技有限公司 一种间充质干细胞的制备方法和应用
CN117660325B (zh) * 2024-01-31 2024-04-19 苏州科为康生物医药科技有限公司 一种制备脐带血msc的培养基及其方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459307B2 (en) 2001-08-14 2008-12-02 Medipost Co., Ltd Composition for treatment of articular cartilage damage
EP1446015B1 (en) * 2001-10-18 2018-03-14 Lifecell Corporation Remodeling of tissues and organs
JP2005517441A (ja) 2002-02-19 2005-06-16 メディポスト・カンパニー・リミテッド 臍帯血由来の間葉幹細胞・前駆細胞の分離培養方法及び間葉組織への分化誘導方法
AU2003266282A1 (en) * 2002-07-30 2004-02-23 Tigenix N.V. Compositions comprising muscle progenitor cells and uses thereof
US20060252045A1 (en) * 2003-06-06 2006-11-09 Moitreyee Chatterjee-Kishore Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
JP2006055106A (ja) 2004-08-23 2006-03-02 National Institute Of Advanced Industrial & Technology ヒト血清培地を用いるヒト骨髄由来間葉系幹細胞培養法
KR20200123283A (ko) * 2005-12-29 2020-10-28 안트로제네시스 코포레이션 태반 줄기 세포 집단
US20070178073A1 (en) * 2006-02-01 2007-08-02 Samsung Life Public Welfare Foundation Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung Disease
KR20150039214A (ko) * 2007-02-12 2015-04-09 안트로제네시스 코포레이션 태반 줄기세포를 이용한 염증 질환의 치료
US8114668B2 (en) 2007-05-14 2012-02-14 Cardiac Pacemakers, Inc. Composition for cold storage of stem cells
US8017390B2 (en) * 2007-07-20 2011-09-13 Dongguk University Industry-Academic Cooperation Foundation Method for the preparation of dermal papilla tissue employing mesenchymal stem cells
GB0715648D0 (en) * 2007-08-10 2007-09-19 Cambridge Silicon Radio Ltd Channel decoding using similarity matching
ES2352046T3 (es) * 2007-09-21 2011-02-15 Universität Leipzig Medio de cultivo celular y procedimiento de cultivo de células madre y células progenitor.
US20100330047A1 (en) * 2009-06-26 2010-12-30 Life & Light Ltd. Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor
EP2489727A4 (en) * 2009-10-08 2013-05-08 Seoul Nat Univ Hospital METHOD FOR INDUCING HIGH ACTIVITY OF HUMAN ADIPOSE CELLS AND RELATED MEDIA
JP5185470B2 (ja) * 2010-08-03 2013-04-17 北海道公立大学法人 札幌医科大学 自己血清添加骨髄細胞培養システム、自己血清添加骨髄細胞培養方法および自己血清添加培養骨髄細胞を有効成分とする医薬組成物の製造方法
US20120052577A1 (en) 2010-08-31 2012-03-01 The Regents Of The University Of California Culture system for stem cell propagation and neural and oligodendrocyte specification

Also Published As

Publication number Publication date
JP2015532596A (ja) 2015-11-12
CN104781394B (zh) 2017-12-12
EP2893001A1 (en) 2015-07-15
CA2884000C (en) 2021-08-24
US20150284686A1 (en) 2015-10-08
ES2755802T3 (es) 2020-04-23
KR101532556B1 (ko) 2015-06-30
JP6478243B2 (ja) 2019-03-06
US11332715B2 (en) 2022-05-17
DK2893001T3 (da) 2019-12-02
EP2893001B1 (en) 2019-10-30
CA2884000A1 (en) 2014-03-06
PL2893001T3 (pl) 2020-03-31
US9580687B2 (en) 2017-02-28
US10294456B2 (en) 2019-05-21
WO2014035215A1 (en) 2014-03-06
AU2013309642A1 (en) 2015-03-26
CN104781394A (zh) 2015-07-15
PT2893001T (pt) 2019-12-09
EP2893001A4 (en) 2016-03-09
US20170191036A1 (en) 2017-07-06
KR20140030703A (ko) 2014-03-12
AU2013309642B2 (en) 2018-10-25
US20190218517A1 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
IN2015DN01737A (zh)
IN2015DN00934A (zh)
BR112015022770A8 (pt) meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas
JP2015507921A5 (zh)
NZ627091A (en) Host cells with artificial endosymbionts
BR112013002811A8 (pt) meios básicos simplificados para cultura celular pluripotente de humano
WO2012135621A3 (en) Priming of pluripotent stem cells for neural differentiation
WO2012021845A3 (en) Improved hematopoietic stem and progenitor cell therapy
ZA201206635B (en) Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage
HK1222198A1 (zh) 用於提高幹細胞再生能力的培養基組合物及使用它的幹細胞培養方法
MX2014011005A (es) Sistema y sustancias para la crioconservacion de celulas viables.
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
MX2016005824A (es) Metodo de cultivo celular.
MX2013005140A (es) Medios de cultivo de celulas granulados en seco.
WO2011099783A3 (ko) 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
PH12016502330A1 (en) Method for preparing induced pluripotency stem cells from mesenchymal stem cells by using phlorotannin fraction
WO2012074265A3 (ko) 줄기세포의 안정성 증진용 조성물
MX2020014123A (es) Control de niveles de dióxido de carbono y ph en reactores de pequeños volúmenes.
WO2012075462A3 (en) Methods and compositions for treatment of muscular dystrophy
WO2012124978A3 (ko) 3차원 세포배양으로 수득한 조정 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물
WO2011112601A3 (en) Continuous flow bioreactor for magnetically stabilized three-dimensional tissue culture
WO2014072720A3 (en) Cell differentiation
MX2018000589A (es) Recipiente para administracion, almacenamiento o cultivo celular.
WO2012118349A3 (ko) 제대혈 cd14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법
WO2012112776A3 (en) Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors